Along with more intensive studies, an increasing number of tumor suppressor lncRNAs have been discovered, e.g., PDCD4-AS122, LINC0113357, NORAD58, MEG359, XIST60–63, etc. Growing evidence indicates that lncRNAs may become a promising biomarker in breast cancer metastasis. This evidence concerns the gene PDCD4 and breast carcinoma.